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Abstract
Objective: Recent studies have revealed that the ability of cancer cells to undergo 
intermediate state of EMT, partial EMT (p-EMT) poses a higher metastatic risk 
rather than complete EMT. Here we examined the prognostic value of p-EMT-related 
genes in head and neck squamous cell carcinoma (HNSCC) by bioinformatic 
approaches.
Materials and Methods: We used RNA-seq data of 519 primary HNSCC cases 
obtained from TCGA database. We compared the expression of p-EMT-related genes 
in HNSCC tissues with normal tissues. We evaluated the prognostic value of p-EMT-
related genes in HNSCC cases by Log-rank test. We examined the expression of p-
EMT-, EMT-, and epithelial differentiation-related genes by qPCR.
Results: Among p-EMT-related genes that were highly expressed in HNSCC cases, 
high expression of SERPINE1, ITGA5, TGFBI, P4HA2, CDH13, and LAMC2 was 
significantly correlated with poor survival of HNSCC patients. By gene expression 
pattern, HNSCC cell lines were classified into three groups; epithelial phenotype, 
EMT-phenotype, and p-EMT phenotype.
Conclusions: Our findings suggest that p-EMT program may be involved in poor 
prognosis of HNSCC. SERPINE1, ITGA5, TGFBI, P4HA2, CDH13, and LAMC2 can be 
used for a prognostic marker. Moreover, HNSCC cells with p-EMT phenotype can be 
a useful model for investigating a nature of p-EMT.
KEYWORDS
partial-epithelial-to-mesenchymal transition; head and neck squamous cell 
carcinoma; prognosis
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1. INTRODUCTION
Like most epithelial cancers, HNSCC develops through the accumulation of multiple 
genetic and epigenetic alterations in a multistep process. In cancer progression, it is 
known that epithelial-to-mesenchymal transition (EMT) in cancer cells is associated 
with invasion, metastasis, stemness, and resistance of therapy (Nieto et al, 2016). In 
the process of EMT, cancer cells lose their epithelial features, such as intercellular 
connections and E-cadherin expression and gain mesenchymal features. EMT is not 
binary process. It recently has been shown the intermediate state of EMT, partial 
EMT (p-EMT). Cancer cells with p-EMT state act like cancer cells with mesenchymal 
state, but they don’t lose their epithelial feature completely (Pastushenko et al, 
2018). Recent evidences showed that p-EMT program is involved in tumor 
progression and metastasis (Bednarz-Knoll et al, 2012; Saitoh, 2018). Moreover, in 
vivo study has revealed that p-EMT promotes tumor cell migration and formation of 
circulating tumor cell clusters (Aiello et al, 2018). Cells with p-EMT program have 
been referred to as ‘‘metastable’’, reflecting the flexibility of these cells to induce or 
reverse the EMT process (Lee et al, 2014; Tam et al, 2013). Indeed, it has been 
demonstrated that reversion of EMT is essential for disseminated tumor cells to 
proliferate and form metastases in vivo (Ocaña et al, 2012; Tsai et al, 2012). In 
similar to other types of cancer, p-EMT program is dynamic, invasive, and 
potentially responsive to tumor microenvironment cues in HNSCC, demonstrated by 
in vivo profiles and in vitro functional data (Puram et al, 2017). Single-cell RNA-seq 
of HNSCC cells identified p-EMT-related extracellular matrix genes (Puram et al, 
2017). However, the nature of p-EMT and its prognostic value are still unknown. In 
this study, therefore, we examined the prognostic value of p-EMT-related genes by 
using public RNA-Seq data of primary HNSCC cases.
2. MATERIALS AND METHODS
Data analysis. RNA-sequencing data from 43 normal samples and 519 HNSCC 
samples released by TCGA (https://tcga-data.nci.nih.gov/tcga/). There was >10 
year follow up time available for all data points. The RNASeqV2 data from TCGA was 
reanalyzed by R (ver. 3.6.1) and Subio Platform (ver. 1.22, Subio inc., Japan). For 
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investigating prognostic value of p-EMT-related genes in HNSCC cases, we divided 
the cases into two groups, “low” and “high”, based on the median expression level of 
each p-EMT-related gene. Then, we compared the survival rate of “low” group with 
“high” group by log-rank test. Survival curve was made by Survminer package, and 
the heatmap was made by ggplot2 or pheatmap package. For log-rank test, a P-value 
of <0.02 was considered significant. For other analyses, a P-value of <0.05 was 
considered significant.
Cell culture. HSC2, HSC3, and HSC4 cells were provided by Japanese Collection of 
Research Bioresources Cell Bank. HOC313, HOC621, HOC719PE and HOC719NE 
cells were provided from Prof. Kamata (Hiroshima University). We previously found 
that HOC719NE and HOC313 have EMT features including loss of E-cadherin 
expression (Nguyen et al, 2013; Yokoyama et al, 2001). MSCC-inv1 cells were 
previously established in our laboratory. MSCC-inv1 cells were isolated as a high 
invasive clone by using in vitro invasion assay from MSCC-1 cells that were 
established from lymph node metastasis of gingival cancer (Kudo et al, 2003; Kudo 
et al, 2004)
qPCR. Total RNA was isolated from cultures of confluent cells using the RNeasy Mini 
Kit (Qiagen). Preparations were quantified and their purity was determined by 
standard spectrophotometric methods. cDNA was synthesized from 1 µg total RNA 
according to the PrimeScript II reverse transcriptase (Takara Bio Inc.). Expression 
levels of p-EMT, EMT and epithelial differentiation genes were determined using a 
LightCycler 96 system (Roche) with TB Green Premix Ex Taq II (Takara Bio Inc.). 
List of primers is shown in Supplemental Table 1. Relative mRNA expression of each 
transcript was normalized against GAPDH mRNA.
3. RESULTS
Recent single cell transcriptome analysis has identified several genes that are 
involved in p-EMT program (Puram et al, 2017). We focused on the representative 
p-EMT-related genes; 15 common p-EMT-related genes (SERPINE1, TGFBI, MMP10, 
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LAMC2, P4HA2, PDPN, ITGA5, LAMA3, CDH13, TNC, MMP2, EMP3, INHBA, LAMB3, and 
VIM) and 10 valuable p-EMT-related genes (THBS2, CXCL13, FN1, MMP3, MMP9, 
RAB25, MT1X, GPX3, SPP1, and MXD1). To know the prognostic value of these genes, 
we determined their correlation with prognosis by using the RNA-sequencing data 
and clinical information from 43 normal samples and 519 HNSCC samples released 
by TCGA (Figure 1a). First, we compared the expression level of common and 
valuable p-EMT-related genes in primary tumors and normal tissue. Higher 
expression of all common p-EMT-related genes were observed in primary tumors, 
compared to normal tissue (Figure 1b). Among 10 valuable p-EMT-related genes, 
CXCL13, FN1, MMP3, MMP9, SPP1, and THBS2 were highly expressed in primary 
tumors (Figure 1b).
Next, we determined the correlation between the expression levels of p-
EMT-related genes and prognosis in HNSCC cases by Log-rank test. We divided the 
cases into two groups, “low” and “high”, based on the median expression of each p-
EMT-related gene. Then, we compared the survival rate of “low” group with “high” 
group (Figure 2a and Supplementary Figure S1). Among these genes, Serpin Family 
E Member 1 (SERPINE1), transforming growth factor (TGF)-ß-induced (TGFBI), 
Integrin Subunit Alpha 5 (ITGA5), cadherin 13 (CDH13), Prolyl 4-Hydroxylase Subunit 
Alpha 2 (P4HA2), Laminin Subunit Gamma 2 (LAMC2), and Metallothionein 1X 
(MT1X) were significantly correlated with poor prognosis (Figure 2a). These 
molecules besides MT1X were identified as a prognosis-related gene. As MT1X 
expression in HNSCC cases was lower than that in normal tissues (Figure 1b), MT1X 
was excluded. The expression patterns of these prognosis-related genes showed a 
positive correlation between 519 HNSCC samples obtained from TCGA (Figure 2b). 
In the gene expression cluster enriched p-EMT genes, SNAI2, which is involved in 
classical EMT program, was also included (Figure 2b).
To identify the HNSCC cell lines with p-EMT features, we comprehensively 
examined the expression of p-EMT-, EMT- and epithelial differentiation-related 
genes in HNSCC cell lines by qPCR. We used HSC2, HSC3, HSC4, HOC719PE, 
HOC719NE, HOC313, HOC621, and MSCC-inv1 cells in this analysis. As we expected, 
HOC719NE and HOC313 with EMT phenotype showed low expression level of 
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epithelial differentiation-related genes (Figure 3 and Supplementary Figure S2). 
These cells showed high expression level of p-EMT-related genes as well as EMT-
related genes. HSC2, HSC4, and HOC621 cells showed high expression level of 
epithelial differentiation-related genes and low expression level of EMT- and p-
EMT-related genes, suggesting that these cells showed epithelial phenotype. 
HOC719PE, HSC3, and MSCC-inv1 cells showed high expression level of EMT- and p-
EMT-related genes, while they also showed high expression level of epithelial 
differentiation-related genes, suggesting that these cells showed p-EMT phenotype.
MSCC-inv1 cells were isolated from MSCC-1 cells by in vitro invasion assay 
(Figure 4a). We compared the expression of p-EMT-related genes, EMT-related 
genes and epithelial differentiation-related genes by using previous microarray data 
(Kudo et al, 2006). MSCC-inv1 showed higher expression level of p-EMT related 
genes, compared with parent MSCC-1 cells (Figure 4b).
4. DISCUSSION
In this study, we identified the prognosis-related genes, such as SERPINE1, TGFBI, 
ITGA5, CDH13, P4HA2, and LAMC2 among p-EMT-related genes in HNSCC. GO 
enrichment analysis revealed that these prognosis-related genes are correlated with 
cell-substrate adhesion and angiogenesis (Supplemental Figure S3). Upregulation of 
SERPINE1, TGFBI, ITGA5, CDH13, P4HA2, and LAMC2 may be involved in malignant 
behaviors via loss of cell adhesion and promoting angiogenesis. Indeed, there are 
several studies on the involvement of these molecules in cell adhesion and 
angiogenesis. PAI-1, encoded by SERPINE1, is an indicator of poor prognosis in 
different types of cancer by TCGA database analysis (Li et al, 2018). In HNSCC, high 
PAI-1 expression was associated with a higher rate of metastasis development and 
poor clinical outcome in HNSCC patient (Chin et al, 2005; Speleman et al, 2007; 
Pavón et al, 2015). Overexpression of PAI-1 accelerated HNSCC cell migration 
mediated by the activation of PI3K/AKT pathway (Pavón et al, 2015). Moreover, PAI-
1 is involved in angiogenesis in several types of cancer (Li et al, 2018). Interestingly, 
PAI-1 is regarded as a mesenchymal marker and thoroughly confirmed to be a 
pivotal downstream effector on EMT induced by TGF-β in various cancer cell lines 
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(Omori et al, 2016; Chung et al, 2018; Wang et al, 2017). TGFBI is a 68 kDa 
matricellular protein and a member of the fasciclin domain containing protein 
family that also includes periostin (Skonier et al, 1992). Although many reports 
indicate that TGFBI functions as a tumor suppressor, there is also convincing data in 
the literature reporting a tumor-promoting role for TGFBI. In our previous study, 
periostin is identified as an invasion promoting factor in HNSCC (Kudo et al, 2006). 
Indeed, periostin expression was only observed in EMT-induced HNSCC cells. In 
previous study, TGFBI is considered as a p-EMT marker and TGFBI positive HNSCC 
cells is used as p-EMThigh population (Puram et al, 2017). Interestingly, p-EMThigh 
population showed higher invasiveness than p-EMTlow population. ITGA5 and 
P4HA2 are involved in HIF related hypoxia pathway, which causes tumor 
angiogenesis and hematogenous metastasis (Toss et al, 2018; Koike et al, 2004). 
LAMC2 is involved in cellular migration and adhesion (Fukushima et al, 1998). 
CDH13, an atypical member of the cadherin family, has been associated with poorer 
prognosis in various carcinomas (Andreeva et al, 2010). CDH13 is upregulated in 
blood vessels growing through tumors and promotes tumor neovascularization 
(Andreeva et al, 2010). Thus, previous reports revealed that p-EMT genes that we 
identified as a prognosis-related gene were involved in tumor progression (Figure 
5). During p-EMT program, these molecules may cooperate each other for 
unfavorable behaviors in HNSCC. To clarify the detailed mechanism, further studies 
will be required.
In the previous studies, HNSCC cases are classified by gene expression 
profiles (Chung et al, 2004; Pavón et al, 2012; Walter et al, 2013; De Cecco et al, 
2015). In all studies, basal group (epithelial phenotype) showed better prognosis 
than other groups. De Cecco et al. classified HNSCC cases as 6 groups (Cl1-Cl6); 
human papilloma virus (HPV)-like (Cl1), mesenchymal (Cl2), hypoxia associated 
(Cl3), inflammatory (Cl4), classical (Cl5), and immunoreactive (Cl6) by a meta-
analysis approach (De Cecco et al, 2015). Among them, Cl2 and Cl3 show a more 
aggressive behavior. EMT-related genes were included in Cl2, common p-EMT-
related genes were included in Cl3, Cl4, and Cl5. Chung et al. classified HNSCC cases 
as 4 groups (G1-G4). G3 and G4 showed poorer prognosis than G1 and G2. 
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Interestingly, p-EMT-related genes were included in G3 and G4. Epithelial 
differentiation-related genes were included in G1 and EMT-related genes were 
included in G2. Cumulative findings indicate that p-EMT genes are involved in poor 
prognosis.
EMT is not binary process. There are many cells in intermediate state of 
EMT, and the ability of proliferation, invasion and metastasis is different among each 
subpopulation (Pastushenko et al, 2018). Recently, it is recognized that the ability 
of cancer cells to undergo p-EMT, rather than complete EMT, poses a higher 
metastatic risk (Saitoh, 2018). qPCR analysis in HNSCC cell lines classified into three 
groups; epithelial phenotype, p-EMT phenotype, and EMT phenotype (Figure 3). 
This finding helps us to examine the nature of p-EMT and/or EMT in HNSCC. As the 
nature of p-EMT is still unknown, HOC719 PE, HSC3 and MSCC-inv1 cells can be used 
as a useful cell model for investigating a nature of p-EMT. Moreover, it is interesting 
to examine how the cells lose the expression of epithelial differentiation-related 
genes during EMT induction by using these cell lines. We think that this mechanism 
may be the key for understanding the involvement of p-EMT and/or EMT-related 
genes in malignant behaviors of HNSCC.
In conclusion, p-EMT program may be involved in poor prognosis of HNSCC. 
The p-EMT-related genes we identified in this study can be used for prognostic 
marker in HNSCC. However, it is still unknown how cancer cells require the 
phenotype of p-EMT during cancer progression. To understand the mechanism of p-
EMT induction may lead to develop novel diagnosis and therapy for HNSCC.
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Figure legends
Figure 1. Study overview. (a) From TCGA-HNSCC RNA-seq data, we picked up the 
gene expression of p-EMT-related genes. To confirm the higher expression of p-
EMT-related genes in HNSCCs, we compared the expression levels of HNSCC tissues 
with normal tissues. We also examined the correlation between p-EMT-related 
genes and prognosis of HNSCC patients. Then, we identified the p-EMT-related 
genes that are involved in poor survival; (b) p-EMT-related genes including common 
p-EMT and variable p-EMT genes are highly expressed in TCGA HNSCC tumors 
(n=519) compared to normal epithelium (n=43). 
Figure 2. Correlation of the expression of p-EMT-related genes and poor prognosis. 
(a) Patients with high expression of p-EMT-related genes show poor disease-free 
survival. Red-high and blue-low expression of p-EMT-related genes as assessed 
from the TCGA data; (b) Heatmap shows the pairwise correlation in gene expression 
between 519 HNSCC samples obtained from TCGA. Correlation heatmap visualized 
three gene expression clusters. Each cluster enriched EMT-, p-EMT-, and epithelial 
differentiation-related genes were highlighted in red, yellow and blue, respectively. 
Purple circles highlighted the prognosis-related genes.
Figure 3. Expression of epithelial differentiation-, p-EMT-, and EMT-related genes 
in HNSCC cell lines. Heatmap shows epithelial differentiation-, p-EMT-, and EMT-
related genes (rows) that are differentially expressed across HNSCC cell lines 
(columns). Purple circles highlighted the prognosis-related genes.
Figure 4. Expression of epithelial differentiation-, p-EMT-, and EMT-related genes 
in MSCC-1 and MSCC-inv1 cells. (a) Highly invasive clone, MSCC-inv1 cells were 
previously isolated from parent MSCC-1 cells by using in vitro invasion assay; (b) 
Graph shows the fold change of the expression of epithelial differentiation-, p-EMT-, 
and EMT-related genes in MSCC-inv1 cells. Among these genes, PDPN, TNC, MMP2, 
VIM, CXCL13, FN1, MMP3, RAB25, MT1X, GPX3, EPCAM, KRT15, KRT6B, KRT6C, KRT17, 
KRT75, S100A7, S100A9, ZEB1, ZEB2, SNAI2, and SNAI1 were not expressed in both 
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MSCC-1 and MSCC-inv1 cells. Purple circles highlighted the prognosis-related genes.
Figure 5. Schematic model for involvement of prognosis-related p-EMT gene in 
unfavorable behaviors of HNSCC. TGFBI, SERPINE1, and CDH1 inhibit cell-cell 
adhesion. SERPINE1, CDH13, ITGA5, LAMC2 promote migration. SERPINE1 promotes 
angiogenesis via HIF-1-VEGF axis. CDH13 promotes angiogenesis. ITGA5 promotes 
angiogenesis via PI3K-AKT signaling pathway. SERPINE1, ITGA5, LAMC2, and P4HA2 
are involved in extracellular matrix organization.
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